Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
4.21
Funders
Alzheimer's Association
National Institutes of Health
Houston Methodist Research Institute
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial
Michael Grundman, Stanley H. Appel, Michael George, Belén Pascual et al.
Citations
5 citations
Journal
Alzheimer s Research & Therapy
Topics
Neuroinflammation and Neurodegeneration Mechanisms
Field-Weighted Citation Impact (FWCI)
4.21
article
Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial
Michael Grundman, Stanley H. Appel, Michael George, Belén Pascual, Joseph C. Masdeu, Jason R. Thonhoff, David R. Beers, Daling Li, Aaron D. Thome, Jon B. Toledo, Alireza Faridar, Nazaret Gamez, Mohammad Obadah Nakawah, Weihua Zhao, Gustavo C. Román, John Volpi, Charles S. Davis, Yanling Wang, Reena Boradia
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
Alzheimer s Research & TherapyVol. 17(1)
Institutions
Houston Methodist (US), University of San Diego (US), Neurosciences Institute (US), University of California San Diego (US), Partners In Care (US), Methodist Hospital (US), Community Science and Data Center (US)
Funders
Alzheimer's Association, National Institutes of Health, Houston Methodist Research Institute
Sustainable Development Goals
Good health and well-being
OpenAlex Percentile
Openalex Percentile: Top 6%
Topics
Neuroinflammation and Neurodegeneration Mechanisms
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial — Michael Grundman, Stanley H. Appel, et al. · Alzheimer s Research & Therapy (2025) | TGRS Research Map | TGRS